Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H22N2O2 |
InChIKeyPEHYINMYYPHEER-RXFWQSSRSA-N |
CAS Registry1826116-38-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | PT | 10 Aug 2019 |